Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity
Journal of Controlled Release · 2025-02 · 378 · 170-194
DOI: 10.1016/j.jconrel.2024.12.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2025-02. Verfasst von Mahboubeh Hosseini-Kharat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Health Sciences, Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: DNA, Gene Transfer Techniques, Genetic Therapy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 294 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA-based therapies are often limited by challenges such as stability, long-term integration, low transfection efficiency, and insufficient targeted DNA delivery. This review focuses on recent progress in the design of non-viral delivery systems for enhancing targeted DNA delivery and modulation of therapeutic efficiency. Cellular uptake and intracellular trafficking mechanisms play a crucial role in optimizing gene delivery efficiency. There are two main strategies employed to improve the efficiency of gene delivery vectors: (i) explore different administration routes (e.g., mucosal, intravenous, intramuscular, subcutaneous, intradermal, intratumoural, and intraocular) that best facilitates optimal uptake into the targeted cells and organs and (ii) modify the delivery vectors with cell-specific ligands (e.g., natural ligands, antibodies, peptides, carbohydrates, or aptamers) that enable targeted uptake to specific cells with higher specificity and improved biodistribution. We describe how recent progress in employing these DNA delivery strategies is advancing the field and increasing the clinical translation and ultimate clinical application of DNA therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Health Sciences, Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia.
- Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
- Clinical and Health Sciences, Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia. Electronic address: clive.prestidge@unisa.edu.au.
Zitieren
APA
Hosseini-Kharat, M., Bremmell, K. E., Grubor-Bauk, B., & Prestidge, C. A. (2025). Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity. Journal of Controlled Release, 378, 170-194. https://doi.org/10.1016/j.jconrel.2024.12.002
Vancouver
Hosseini-Kharat M, Bremmell KE, Grubor-Bauk B, Prestidge CA. Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity. Journal of Controlled Release. 2025;378:170-194. doi:10.1016/j.jconrel.2024.12.002
BibTeX
@article{HosseiniKharat2025,
author = {Hosseini-Kharat, Mahboubeh and Bremmell, Kristen E and Grubor-Bauk, Branka and Prestidge, Clive A},
title = {Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity},
journal = {Journal of Controlled Release},
year = {2025},
volume = {378},
pages = {170--194},
doi = {10.1016/j.jconrel.2024.12.002}
}
EUVIMED